Drug Kickback Ruling Will Make FCA Liability Harder To Prove

By Sean O鈥機onnell, Alison Schurick and Emily Kesler
February 28, 2025, 6:01 PM EST

In聽U.S. v. Regeneron Pharmaceuticals Inc., decided by the U.S. Court of Appeals for the First Circuit on Feb. 18,聽the government alleged that the company violated the Anti-Kickback Statute by covering patient...

Already a subscriber? Click here to view full article